Blog
AngloGold Ashanti Hits 52-Week High: What's Driving Its Performance?
AngloGold Ashanti PLC AU scaled a new 52-week high of $91.65 on Friday before ending the session lower at $91.25. The increase was fueled by near-record gold prices.
The company currently has a
Top 5 High-Yield S&P 500 Stocks to Buy for 2026
The U.S. stock market has experienced significant volatility at the beginning of 2025 owing to a multitude of factors. The trade policy framework undertaken in the new Trump administration has
Earnings Estimates Moving Higher for Innovative Solutions and Support (ISSC): Time to Buy?
Investors might want to bet on Innovative Solutions and Support, Inc. (ISSC), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid
Why Commercial Metals (CMC) Might be Well Poised for a Surge
Commercial Metals (CMC) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue
How Deutsche Bank Plans to Achieve RoTE Above 13% by 2028
Deutsche Bank AG DB has laid out an ambitious but structured plan to lift its return on tangible equity (RoTE) above 13% by 2028. The strategy rests on a combination of revenue growth, tighter cost
Can OpenAI-led Conversational Commerce Drive TGT's Next Growth Wave?
OpenAI is emerging as a key strength in Target Corporation’s TGT next phase of digital transformation, as the retailer leans heavily on conversational commerce to reaccelerate growth. In
Rare Earth Metal Stocks Quietly Break Out Again
Rare earth metal stocks were among the hottest investment themes earlier this year, only to fade from the spotlight in recent months. Now, just as the sector has slipped out of the investor
Is KMB's Brand Investment Strategy Enhancing Its Competitive Edge?
Kimberly-Clark Corporation's KMB brand investment strategy is evolving as a bedrock of its competitive positioning, supporting management’s ambition to build an industry-leading personal care
Is Colgate's Productivity Program a Catalyst for Its Margins?
Colgate-Palmolive Company’s CL Strategic Growth and Productivity Program is emerging as a critical lever in its margin story, particularly as the company navigates cost inflation and uneven category
Alps Electric (APELY) Upgraded to Buy: What Does It Mean for the Stock?
Alps Electric (APELY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --
Beyond Meat (BYND) Upgraded to Buy: Here's What You Should Know
Investors might want to bet on Beyond Meat (BYND), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one
Magna (MGA) Upgraded to Buy: Here's What You Should Know
Magna (MGA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most
Planet Fitness (PLNT) Upgraded to Buy: Here's What You Should Know
Planet Fitness (PLNT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
Royal Bank (RY) Upgraded to Buy: Here's What You Should Know
Royal Bank (RY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock
Farmers National (FMNB) Upgraded to Buy: What Does It Mean for the Stock?
Farmers National Banc (FMNB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --
All You Need to Know About Immuneering (IMRX) Rating Upgrade to Buy
Immuneering Corporation (IMRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces
ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why
ADC Therapeutics SA (ADCT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings
NVR (NVR) Upgraded to Buy: Here's Why
NVR (NVR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy
Investors might want to bet on BiomX Inc. (PHGE), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
January Effect 2026: 4 Beaten-Down Stocks Poised for a Strong Rebound
In 2025, businesses across sectors witnessed rapid artificial intelligence (AI) advancements that shaped their growth trajectory.The growing concern of an AI bubble along with ongoing tariff war
Here's Why Investors Should Retain MarketAxess Stock for Now
MarketAxess Holdings Inc. MKTX is well-poised for growth, driven by improving trading volumes, acquisitions and partnerships and a robust financial position supporting expansion and shareholder
Coca-Cola's Story: Can Organic Growth Stay Resilient in 2026?
The Coca-Cola Company KO enters the final quarter of 2025 with organic growth momentum that underscores the strength of its all-weather strategy. In the third quarter of 2025, the company delivered
Pre-Market In Red
Our major market indexes have flattened on low seasonal volume of late, and are slipping in early trading in the third-final trading day of 2025. The Dow is currently -52 points, the S&P 500 is -20



